Mau S E
Department of Physiology, Panum Institute, University of Copenhagen, Denmark.
J Mol Endocrinol. 1997 Jun;18(3):181-91. doi: 10.1677/jme.0.0180181.
The present study deals with the effects of withdrawal of dopamine (DA) on the translocation of protein kinase C (PKC) isozymes and release of prolactin (Prl) in resting- and substance P (SP)-stimulated cultures of enriched rat pituitary lactotrophs. Following a brief tonic input (10 min), DA withdrawal induced a redistribution of PKC alpha- and beta-immunoreactivity (IR) to the particulate fraction with maximal levels, attained after 5 min, remaining translocated for 20 min. DA withdrawal prolonged the effect of SP-induced translocation of PKC alpha- and beta-IR. Similar effects were detected when the catalytic activity of PKC in response to DA withdrawal was evaluated. Thus, DA washout redistributed PKC catalytic activity and prolonged the effect of SP on catalytical PKC translocation to the particulate fraction. Pretreatment of cells with the protein kinase A inhibitor, rp-adenosine-3',5'-cyclic monophosphothionate (rp-cAMP), reduced the amount of PKC alpha- and beta-IR redistributed after DA withdrawal. Furthermore, this treatment also reduced the DA withdrawal effect on SP-mediated translocation of PKC alpha- and beta-IR. Methoxyverapamil, a blocker of voltage-gated Ca2+ channels, completely inhibited the redistribution of PKC isozymes after DA withdrawal, but also reduced the potentiating effect of DA withdrawal on SP-induced redistribution of PKC isozyme-IR. In perifused enriched lactotrophs, DA withdrawal induced a release of Prl that lasted 45-55 min and prolonged the effect of SP on Prl secretion. rp-cAMP did not significantly affect Prl release due to DA removal, but the prolonging effect of DA withdrawal on SP-induced Prl secretion was abolished. Methoxyverapamil completely abolished the rebound release of Prl after DA withdrawal, and the potentiating effect of DA removal on SP-mediated Prl release was also diminished. Readdition of DA after DA withdrawal was able to suppress the translocation of PKC isozyme-IR and catalytic activity and to reduce the release of Prl to baseline levels. Moreover, readdition of DA reduced the potentiating effects of DA withdrawal on the same parameters after SP-stimulation of cells. On the basis of these results it is concluded that in resting cells following DA withdrawal prolactin is released and specific PKC isozymes and concomitant catalytic activity are translocated to the particulate fraction in enriched lactotrophs. While cAMP/PKA and influx of Ca2+ seem to work in concert in translocating PKC, influx of Ca2+ is the primary mechanism responsible for the rebound release of Prl after DA withdrawal. DA withdrawal exerts a potentiating effect on SP-induced PKC translocation and Prl release. It is suggested that the biochemical events involved in these processes are cAMP/PKA and Ca2+ influx.
本研究探讨了多巴胺(DA)撤除对富集的大鼠垂体催乳素细胞静息培养物和P物质(SP)刺激培养物中蛋白激酶C(PKC)同工酶转位及催乳素(Prl)释放的影响。经过短暂的持续性输入(10分钟)后,DA撤除诱导PKCα和β免疫反应性(IR)重新分布至颗粒部分,5分钟后达到最高水平,并在20分钟内保持转位状态。DA撤除延长了SP诱导的PKCα和β-IR转位的效应。当评估PKC对DA撤除的催化活性时,也检测到了类似的效应。因此,DA洗脱使PKC催化活性重新分布,并延长了SP对催化性PKC转位至颗粒部分的效应。用蛋白激酶A抑制剂rp-腺苷-3',5'-环磷酸硫代酸盐(rp-cAMP)预处理细胞,可减少DA撤除后重新分布的PKCα和β-IR的量。此外,这种处理还降低了DA撤除对SP介导的PKCα和β-IR转位的影响。甲氧基维拉帕米是一种电压门控Ca2+通道阻滞剂,它完全抑制了DA撤除后PKC同工酶的重新分布,但也降低了DA撤除对SP诱导的PKC同工酶-IR重新分布的增强作用。在灌注的富集催乳素细胞中,DA撤除诱导Prl释放,持续45 - 55分钟,并延长了SP对Prl分泌的效应。rp-cAMP对DA撤除引起的Prl释放没有显著影响,但DA撤除对SP诱导的Prl分泌的延长作用被消除。甲氧基维拉帕米完全消除了DA撤除后Prl的反弹释放,并且DA撤除对SP介导的Prl释放的增强作用也减弱了。DA撤除后重新添加DA能够抑制PKC同工酶-IR的转位和催化活性,并将Prl释放降低至基线水平。此外,重新添加DA降低了DA撤除对细胞经SP刺激后相同参数的增强作用。基于这些结果得出结论,在静息细胞中,DA撤除后催乳素释放,并且在富集的催乳素细胞中特定的PKC同工酶及其伴随的催化活性转位至颗粒部分。虽然cAMP/PKA和Ca2+内流似乎在PKC转位过程中协同作用,但Ca2+内流是DA撤除后Prl反弹释放的主要机制。DA撤除对SP诱导的PKC转位和Prl释放具有增强作用。提示参与这些过程的生化事件是cAMP/PKA和Ca2+内流。